• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Will Johnson & Johnson Be a Trillion-Dollar Stock by 2030?

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 03, 2024 at 10:03: PM
via
  • Johnson & Johnson has been leaning on acquisitions lately to strengthen its portfolio of products.
  • The company expects to grow at an annual rate of around 5% or better until the end of the decade.

article source
 




Top Bottom
Back
Quote